CRISPR Therapeutics AG short interest in 2025
In 2025, CRISPR Therapeutics AG's disclosed short interest ran from 23.80% of shares outstanding on 15 Jan 2025 to 22.09% on 31 Dec 2025, a change of -1.71 percentage points. The year's high was 29.58% on 30 Jun 2025 and its low 22.09% on 31 Dec 2025, averaging 24.54% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.19 days on 31 Dec 2025. Full history: CRISPR Therapeutics AG.
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 23.80% (15 Jan 2025)
- End of year
- 22.09% (31 Dec 2025)
- Change
- -1.71 pp
- High
- 29.58% (30 Jun 2025)
- Low
- 22.09% (31 Dec 2025)
- Average
- 24.54%
- Highest days to cover
- 14.19 (31 Dec 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 23.80% | 11.26 | |
| 31 Jan 2025 | 22.84% | 9.37 | |
| 14 Feb 2025 | 23.79% | 7.68 | 10-K filed, results (8-K) |
| 28 Feb 2025 | 24.26% | 7.53 | |
| 14 Mar 2025 | 23.68% | 12.00 | |
| 31 Mar 2025 | 23.91% | 11.65 | |
| 15 Apr 2025 | 24.21% | 7.23 | |
| 30 Apr 2025 | 24.86% | 13.58 | |
| 15 May 2025 | 24.39% | 9.88 | 10-Q filed, results (8-K) |
| 30 May 2025 | 23.78% | 10.62 | |
| 13 Jun 2025 | 24.79% | 8.48 | |
| 30 Jun 2025 | 29.58% | 5.83 | |
| 15 Jul 2025 | 29.29% | 7.71 | |
| 31 Jul 2025 | 27.15% | 5.78 | |
| 15 Aug 2025 | 25.63% | 7.22 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 24.27% | 12.70 | |
| 15 Sep 2025 | 26.18% | 12.63 | |
| 30 Sep 2025 | 23.48% | 7.70 | |
| 15 Oct 2025 | 23.14% | 6.79 | |
| 31 Oct 2025 | 23.13% | 9.89 | |
| 14 Nov 2025 | 24.33% | 8.57 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 23.54% | 9.25 | |
| 15 Dec 2025 | 22.94% | 12.30 | |
| 31 Dec 2025 | 22.09% | 14.19 |
See also: CRISPR Therapeutics AG's full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.